NeuroMab™ Anti-NRP1B Antibody, Clone IRCR-101 (3H10)
Functional antibody against Human NRP1B
- Host Species:
- Human
- Species Reactivity:
- Human
- Applications:
- FC; ELISA; Inhib; In Vitro; In Vivo
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
SPECIFIC INQUIRY
inquiryDescription
Species Reactivity
Clonality
Host Species
Clone Number
Applications
Formulation
Preservatives
Concentration
Purification
Purity
Endotoxin Level
Low Endotoxin < 1 EU/mg
Shipping
Storage
Research Use Only
Target
Official Name
Alternative Names
Figure 1 shows the Coomassie staining of each purified scFv antibody fragment.
Figure 10 shows the results of the inhibitory effect of IRCR-101 (3H10) on neovascularization in a subcutaneous model of glioblastoma.
Figure 11 shows the results of changes in signal elements involved in IRCR-101 processing.
Figure 12 shows the distribution of IRCR-101 in an orthotopic model of glioma cell lines.
Figure 2 shows the results of an ELISA showing the binding ability of three anti-NrP1 scFv antibodies to NRP1.
Figure 3 shows the results of ELISA showing the binding ability to NRP1 according to the concentration of three anti-NRP1 antibody fragments.
Figure 4 is a confocal laser scanning micrograph showing the internalization function of three anti-NrP1 scFv antibodies.
Figure 5 shows the results of inhibition of cell migration of anti-NrP1 scFv antibody fragments using the U87MG cell line.
Figure 6 shows the purity of production of the three anti-NRP1 IgG antibodies.
Figure 7 shows the results of cancer cell-specific internalization using FACS.
Figure 8 shows the binding activity of IRCR-101(3H10) against cancer-specific NRP1 in a xenograft model of glioma cell lines.
Figure 9 shows the binding ability of IRCR-101 (3H10) to cancer-specific NRP1 in glioblastoma patient samples.
Publications (0)
